IL-17A驱动纤维细胞-中性粒细胞-NET轴,以加剧肺部的免疫病理学,扩散的膜损伤
1State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
研究人员确定了一条关键的炎症途径,涉及扩散膜损伤 (DAD) 中的介质素-17A (IL-17A),中性粒细胞和中性粒细胞细胞外陷 (NET). 这一发现为治疗DAD和其他肺炎疾病提供了潜在的点.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
背景情况:
- 扩散膜损伤 (DAD) 是一种严重的肺损伤,没有向治疗.
- DAD免疫病理学的细胞和分子驱动因素尚未完全理解.
研究的目的:
- 为了阐明细胞和分子机制驱动素诱导的DAD免疫病理学.
- 为了确定DAD的潜在治疗点.
主要方法:
- 单细胞RNA测序的一个细胞.
- 功能性测试是指功能性测试.
- 在素诱导的DAD小鼠模型中的遗传和药理干预.
主要成果:
- 活性中性粒细胞和中性粒细胞细胞外陷 (NETs) 在DAD中积累并加剧炎症和组织损伤.
- 干白素-17A (IL-17A) 信号传递被上调,并驱动中性粒细胞的招募和NET形成.
- IL-17A刺激纤维细胞产生中性粒细胞化学吸引剂CXCL1,其中第3型先天性淋巴细胞 (ILC3) 被确定为主要IL-17A来源.
结论:
- 一个致病性IL-17A-中性细胞-NET轴在DAD中放大了肺免疫病理学.
- 针对这个轴可能为DAD和其他炎症性肺部疾病提供治疗策略.
更多相关视频
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
09:00Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
Published on: June 24, 2020
相关概念视频
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
